Protalix BioTherapeutics
PLX
#8910
Rank
C$0.19 B
Marketcap
C$2.44
Share price
1.74%
Change (1 day)
6.38%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2025 (TTM): C$12.71 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are C$61.94 Million. In 2024 the company made an earning of C$7.27 Million a decrease over its 2023 earnings that were of C$16.39 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$12.71 M74.77%
2024 C$7.27 M-55.62%
2023 C$16.39 M-199.05%
2022 -C$16.55 Million-40.38%
2021 -C$27.76 Million-732.31%
2020 C$4.38 M-130.53%
2019 -C$14.38 Million189.85%
2018 -C$4.97 Million-95.29%
2017 -C$0.11 Billion308.12%
2016 -C$25.82 Million-32.37%
2015 -C$38.17 Million10.11%
2014 -C$34.67 Million-7.59%
2013 -C$37.52 Million
2011 -C$43.44 Million-19.39%
2010 -C$53.89 Million20.87%
2009 -C$44.59 Million32.26%
2008 -C$33.71 Million-5.46%
2007 -C$35.66 Million
2004 -C$0.24 Million12.35%
2003 -C$0.21 Million-11.1%
2002 -C$0.24 Million-57.03%
2001 -C$0.54 Million1.03%
2000 -C$0.54 Million-53.22%
1999 -C$1.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amicus Therapeutics
FOLD
C$6.94 M-45.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$0.81 B 6,251.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.52 B 128,978.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$2.47 B 19,198.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel